Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC) ; volume:20 ; number:1 ; day:3 ; month:12 ; year:2020 ; pages:1-16 ; date:12.2020
BMC cancer ; 20, Heft 1 (3.12.2020), 1-16, 12.2020

Urheber
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12885-020-07690-8
URN
urn:nbn:de:101:1-2021011218333780403553
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:21 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

Ähnliche Objekte (12)

Hyper-Progressive Disease (HPD) during Immune Checkpoint Inhibitor (ICI) Therapy

Hyper-Progressive Disease (HPD) during Immune Checkpoint Inhibitor (ICI) Therapy

ASCO 2020 non-small lung cancer (NSCLC) personal highlights

ASCO 2020 non-small lung cancer (NSCLC) personal highlights

Combination of Local Ablative Therapy and Continuation of Immune Checkpoint Inhibitor (ICI) Therapy Provides Durable Treatment Response Past Oligometastatic Progression in NSCLC: A Case Report

Combination of Local Ablative Therapy and Continuation of Immune Checkpoint Inhibitor (ICI) Therapy Provides Durable Treatment Response Past Oligometastatic Progression in NSCLC: A Case Report

Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC

Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC

Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer

Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer

Relation between ocular paraneoplastic syndromes and Immune Checkpoint Inhibitors (ICI): review of literature

Relation between ocular paraneoplastic syndromes and Immune Checkpoint Inhibitors (ICI): review of literature

Firmenstudie ICI

Firmenstudie ICI

Dessinservice ICI

Archivale

Dessinservice ICI

P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC)

P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC)

Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke

Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke

Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients

Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients

Über Ici et ailleurs : = On Ici et ailleurs

Über Ici et ailleurs : = On Ici et ailleurs

Verbundene Objekte